Jan 11, 2022 / 01:15PM GMT
Casey Rene Woodring - JPMorgan Chase & Co, Research Division - Research Analyst
Hi. My name is Casey Woodring from the Life Science Tools equity research team here at JPM. Welcome to our Annual Healthcare Conference.
I'm pleased to introduce our next company, SOPHiA Genetics. Just a quick reminder before I hand it off to the management team, if you would like to ask a question during the Q&A portion of the presentation, there's an option to do so on the conference website. And with that, I'll turn it over to Jurgi. Thanks.
Jurgi Camblong - SOPHiA GENETICS SA - Founder, CEO & Director
Thank you so much, Casey. I'm excited to be here today. Welcome to everyone, and thank you for attending our presentation. It's the first time that SOPHiA GENETICS is presenting at the JPMorgan Healthcare Conference as a public company. And I may say that I'm very eager to share our story with all of you.
Before I start the presentation, I want to remind everyone that I will be making some forward-looking statements for which actual results may differ
Sophia Genetics SA at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
